Analysis of the Broad Institute’s Cancer Cell Line Encyclopedia (CCLE) revealed that DYRK1A was overexpressed in hematopoietic malignancies, especially in BCP-ALL, relative to other tumor types (Supplementary Fig. 4f, g). Here, DYRK1A is linked to cancer.